dalteparin has been researched along with Elevated Cholesterol in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"High cholesterol levels are a known risk factor for coronary events." | 1.31 | Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin. ( Baetta, R; Camera, M; Comparato, C; Ezekowitz, MD; Fuortes, M; Paoletti, R; Rossi, F; Toschi, V; Tremoli, E, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miguélez, A | 1 |
Barrientos, N | 1 |
López-Ríos, F | 1 |
Vanaclocha, F | 1 |
Iglesias, L | 1 |
Camera, M | 1 |
Toschi, V | 1 |
Comparato, C | 1 |
Baetta, R | 1 |
Rossi, F | 1 |
Fuortes, M | 1 |
Ezekowitz, MD | 1 |
Paoletti, R | 1 |
Tremoli, E | 1 |
Deepa, PR | 2 |
Varalakshmi, P | 2 |
4 other studies available for dalteparin and Elevated Cholesterol
Article | Year |
---|---|
Necrotic livedo reticularis, multiple cholesterol emboli and ANCA.
Topics: Abdomen; Aged; Buttocks; Diagnosis, Differential; Embolism, Cholesterol; Enoxaparin; Humans; Hyperch | 2003 |
Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin.
Topics: Animals; Anticholesteremic Agents; Anticoagulants; Aorta; cdc42 GTP-Binding Protein; Cells, Cultured | 2002 |
Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
Topics: Animals; Aorta; Arteriosclerosis; Diet, Atherogenic; Glycosaminoglycans; Heparin, Low-Molecular-Weig | 2005 |
Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
Topics: Animals; Anticoagulants; Atherosclerosis; Biomarkers; Blood Proteins; Disease Models, Animal; Hepari | 2006 |